Search results
22 hours ago · Die Roche-Tochter Genentech hat von der US-Arzneimittelaufsicht FDA die Zulassung für ihre zweimal jährlich zu verabreichende subkutane Injektionsbehandlung für Patienten mit zwei Arten von ...
22 hours ago · (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's under-the-skin injection to treat patients with multiple sclerosis. The therapy is already approved as an infusion or ...
6 hours ago · Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics.
5 hours ago · Patriots 21, Seahawks 13 Dan Roche, WBZ-TV Sports. Week 1 and Week 2 are strange ones, historically, in the NFL. Just because the Patriots stunned the Bengals in Week 1 on the road, it guarantees ...
- 11 min
- Matt Geagan
6 hours ago · Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics.
4 hours ago · Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis
22 hours ago · Roche RHHBY announced that the FDA has approved the subcutaneous (SC) formulation of the blockbuster immunotherapy drug Tecentriq (atezolizumab). The SC formulation was approved under the brand name Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs). Per Roche, the approval makes Tecentriq ...
